←Back to Expert Scholars
Translational Medicine / 转化医学Theranostics, PSMA and DOTATATE
Ken Herrmann
MD, MBA
🏢University Hospital Essen🌐Germany
Professor and Chair of Nuclear Medicine
80
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ken Herrmann is a global leader in radionuclide theranostics based in Essen and a driving force behind European PSMA and DOTATATE therapy programs. He has led clinical trials of lutetium-177 PSMA therapy and helped establish theranostic training in Europe. His work advances radioligand therapy worldwide.
Share:
🧪Research Fields 研究领域
PSMA theranostics
DOTATATE therapy
radioligand therapy
European theranostics leadership
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ken Herrmann 的研究动态
Follow Ken Herrmann's research updates
留下邮箱，当我们发布与 Ken Herrmann（University Hospital Essen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment